Dabigatran appears to be feasible and safe in the management of non-AF associated acute ischaemic stroke or TIA, an Australian study shows. The phase 2 DATAS II study randomised 305 stroke /TIA patients to either dabigatran (mostly 150mg daily) or aspirin (81mg) for 30 days. The study, published in Stroke, reported that no patients in ...
Early dabigatran use safe after minor stroke and TIA
By Mardi Chapman
5 Mar 2020